Presentation and pathophysiology of neuro-COVID
- PMID: 34457013
- PMCID: PMC8366502
- DOI: 10.7573/dic.2021-6-5
Presentation and pathophysiology of neuro-COVID
Abstract
Letter to the Editor commenting on Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1. https://doi.org/10.7573/dic.2020-5-1.
Keywords: COVID-19; SARS-CoV-2; coronavirus; neurological complications; stroke.
Copyright © 2021 Finsterer J, Scorza FA, Scorza CA.
Conflict of interest statement
Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2021/07/dic.2021-6-5-COI.pdf
References
-
- Finsterer J, Scorza FA. Neuropathy of peripheral nerves in COVID-19 is due to pre-existing risk factors, anti-viral drugs, or bedding on the ICU. J Peripher Nerv Syst. 2021 (in press) - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
